A
Adrian C Bateman
Researcher at University Hospital Southampton NHS Foundation Trust
Publications - 146
Citations - 8121
Adrian C Bateman is an academic researcher from University Hospital Southampton NHS Foundation Trust. The author has contributed to research in topics: Cancer & Neoadjuvant therapy. The author has an hindex of 42, co-authored 142 publications receiving 7188 citations. Previous affiliations of Adrian C Bateman include Royal Hampshire County Hospital & National Health Service.
Papers
More filters
Journal ArticleDOI
HLA-DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population.
TL;DR: The findings suggest that the HLA DQB1 locus, and in particular the Hla DQB 1*0303 and *0301 alleles, may play an important role in determining the risk of development and the prognosis of CMM within the UK population.
Journal ArticleDOI
Specialty-specific multi-source feedback: assuring validity, informing training.
Helena Davies,Julian Archer,Adrian C Bateman,Sandra Dewar,Jim Crossley,Janet Grant,Lesley Southgate +6 more
TL;DR: A single, generic multi‐source feedback (MSF) instrument in the UK was proposed as part of the assessment programme for Year 1 specialty training in histopathology.
Journal ArticleDOI
IgG4‐related disease—experience of 100 consecutive cases from a specialist centre
Adrian C Bateman,Emma L. Culver +1 more
TL;DR: To describe the features of 100 consecutive cases referred to a single UK institution in which a diagnosis of IgG4-related disease (IgG4‐RD) was under consideration, a database of Igg4‐related disease cases from around the world was used.
Journal ArticleDOI
Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
TL;DR: It is suggested that genetic variation associated with differential TNFalpha and LTalpha production is unlikely to play a major, independent role in susceptibility to, and perhaps prognosis in, CMM.
ROC-king onwards: intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretation.
Antonio Carroccio,Gabriel Becheanu,Marie E. Robert,Mihai Danciu,Mohammad H. Derakhshan,Mohammad H. Derakhshan,Kamran Ghaffarzadehgan,Sauid Ishaq,Ilaria Russo,Azita Ganji,Andra Neefjes-Borst,Vincenzo Villanacci,Geoffrey Holmes,Roxana Maxim,Kamran Rostami,Matt W Johnson,Anna Bozzola,Amitabh Srivastava,Sherly Mathews,Calvin Heal,Mohammad Rostami-Nejad,Alexandra Ciobanu,Mohammad Reza Zali,Alessandra Mandolesi,Luca Elli,Masoud Sotoudeh,Brigitte Bancel,Angelo Sidoni,Arzu Ensari,Carolina Ciacci,Carlo Catassi,James J. Going,Umberto Volta,Gabrio Bassotti,Stefano Ferrero,Adrian C Bateman,Chris J. J. Mulder,Michelangelo Fiorentino,Michael N. Marsh,Michael N. Marsh,David Aldulaimi,Hamid Mohaghegh,Martina Fiorentino +42 more
TL;DR: In this paper, the authors used receiver operating characteristic (ROC) curve analysis to determine the optimal cut-off between normal and coeliac disease (CD) duodenal mucosa, based on IEL counts on >400 mucosal biopsy specimens.